These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 17003242

  • 1. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A.
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [Abstract] [Full Text] [Related]

  • 2. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 3. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function.
    Király MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, Riddell MC, Vranic M.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E271-83. PubMed ID: 18029442
    [Abstract] [Full Text] [Related]

  • 4. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
    Topp BG, Atkinson LL, Finegood DT.
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283
    [Abstract] [Full Text] [Related]

  • 5. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
    Delghingaro-Augusto V, Décary S, Peyot ML, Latour MG, Lamontagne J, Paradis-Isler N, Lacharité-Lemieux M, Akakpo H, Birot O, Nolan CJ, Prentki M, Bergeron R.
    Am J Physiol Endocrinol Metab; 2012 Jan 15; 302(2):E254-64. PubMed ID: 22045312
    [Abstract] [Full Text] [Related]

  • 6. Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats.
    Ogino T, Zhu M, Murakami T, Kuwajima M, Shima K.
    J Med Invest; 1998 Aug 15; 45(1-4):103-10. PubMed ID: 9864970
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ.
    Acta Diabetol; 2005 Dec 15; 42(4):162-70. PubMed ID: 16382303
    [Abstract] [Full Text] [Related]

  • 8. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
    Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P.
    J Nucl Med; 2006 Apr 15; 47(4):689-97. PubMed ID: 16595504
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
    Dhalla AK, Santikul M, Chisholm JW, Belardinelli L, Reaven GM.
    Diabetes Obes Metab; 2009 Feb 15; 11(2):95-101. PubMed ID: 18494808
    [Abstract] [Full Text] [Related]

  • 10. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies.
    Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF.
    Am J Physiol Endocrinol Metab; 2011 Feb 15; 300(2):E255-62. PubMed ID: 21119027
    [Abstract] [Full Text] [Related]

  • 11. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
    Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M.
    Diabetes Metab Res Rev; 2008 Feb 15; 24(8):642-50. PubMed ID: 18973207
    [Abstract] [Full Text] [Related]

  • 12. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
    Smith AC, Mullen KL, Junkin KA, Nickerson J, Chabowski A, Bonen A, Dyck DJ.
    Am J Physiol Endocrinol Metab; 2007 Jul 15; 293(1):E172-81. PubMed ID: 17374701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
    Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH.
    J Biol Chem; 1996 Mar 08; 271(10):5633-7. PubMed ID: 8621426
    [Abstract] [Full Text] [Related]

  • 16. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
    Beha A, Juretschke HP, Kuhlmann J, Neumann-Haefelin C, Belz U, Gerl M, Kramer W, Roden M, Herling AW.
    Am J Physiol Endocrinol Metab; 2006 May 08; 290(5):E989-97. PubMed ID: 16380389
    [Abstract] [Full Text] [Related]

  • 17. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA.
    Am J Physiol Endocrinol Metab; 2005 Jul 08; 289(1):E113-22. PubMed ID: 15727946
    [Abstract] [Full Text] [Related]

  • 18. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
    Gyte A, Pritchard LE, Jones HB, Brennand JC, White A.
    J Neuroendocrinol; 2007 Dec 08; 19(12):941-51. PubMed ID: 18001323
    [Abstract] [Full Text] [Related]

  • 19. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.
    Janssen SW, Martens GJ, Sweep CG, Ross HA, Hermus AR.
    Horm Metab Res; 1999 Nov 08; 31(11):610-5. PubMed ID: 10598829
    [Abstract] [Full Text] [Related]

  • 20. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM, Risovic V, Yuen VG, McNeill JH.
    J Trace Elem Med Biol; 2006 Nov 08; 19(4):251-8. PubMed ID: 16443173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.